Neurobiology Research Unit
Neurobiology Research Unit (NRU) conducts translational neuroscience
research on brain neurotransmission with the aim to promote preventive,
diagnostic and therapeutic advances.
We make use of in vivo molecular, structural, and functional brain
imaging to uncover disease mechanisms and risk correlates as well as to
determine drug effects. We also make use of animal and cell models as
well as human brain tissue to investigate drug effects and diagnostic
value in the clinic. We bring discoveries from cells and animals into
healthy volunteers and patients as early as possible.
NRU is a major training site for pre- and postgraduate students and
relative to its number of staff members it has an outstanding scientific
output. Most of NRU’s budget is covered by external funding.
We will continue to develop new PET- and SPECT-radiotracers for
diagnostics or as biomarkers for use in brain disorders. We will
identify biomarkers and mechanisms behind affective, aggressive,
neurodegenerative and -inflammatory disorders and will develop new
treatment or prevention strategies.
We see our role as being a key unit in the Capital Region to conduct
innovative diagnostic, therapeutic and preventive neuropharmacological
research. This takes place in close interaction with the hospital
clinics, academia and industry enabling immediate subsequent
implementation of prevention strategies, diagnostics and innovative
drugs as well as non-pharmacological treatments of patients with brain
NRU collaborates with many other national and international research institutes.